Literature DB >> 6405387

Development of large granular lymphocytes with anomalous, nonspecific cytotoxicity in clones derived from Ly-2+ T cells.

K Shortman, A Wilson, R Scollay, W F Chen.   

Abstract

T cells cultured at limit dilution for 8 days in a concanavalin A-stimulated, filler-cell and growth factor-supported system produced cytolytic clones with high efficiency. These clones were not specific, lysing a wide range of targets, syngeneic and allogeneic, of tumor and normal cell origin. Lysis was a cell-mediated phenomenon but was not blocked by anti-Ly-2. One H-2-negative target was lysed, but one was resistant. Xenogeneic (human) tumor cells were not lysed. The cells in the clones were large, vacuolated, granular lymphocytes. They originated from single Ly-2+ responder cells and not from irradiated filler cells. Therefore, activated lymphocyte killers and other natural killer-like cells may be differentiated elements of the Ly-2+ T-cell lineage.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6405387      PMCID: PMC393901          DOI: 10.1073/pnas.80.9.2728

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  11 in total

1.  The separation of different cell classes from lymphoid organs. V. Simple procedures for the removal of cell debris. Damaged cells and erythroid cells from lymphoid cell suspensions.

Authors:  K Shortman; N Williams; P Adams
Journal:  J Immunol Methods       Date:  1972-05       Impact factor: 2.303

Review 2.  Natural killer cells.

Authors:  J C Roder; K Karre; R Kiessling
Journal:  Prog Allergy       Date:  1981

Review 3.  Natural killer (NK) cells and their possible roles in resistance against disease.

Authors:  R B Herberman
Journal:  Clin Immunol Rev       Date:  1981

4.  Studies of murine large granular lymphocytes. I. Identification as effector cells in NK and K cytotoxicities.

Authors:  K Kumagai; K Itoh; R Suzuki; S Hinuma; F Saitoh
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

5.  A new assay for cytotoxic lymphocytes, based on a radioautographic readout of 111 In release, suitable for rapid, semi-automated assessment of limit-dilution cultures.

Authors:  K Shortman; A Wilson
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

Review 6.  Quantitation and cloning of cytolytic T lymphocytes and their precursors.

Authors:  H R MacDonald; J C Cerottini; J E Ryser; J L Maryanski; C Taswell; M B Widmer; K T Brunner
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

7.  Propagation of mouse cytotoxic clones with characteristics of natural killer (NK) cells.

Authors:  E Kedar; B L Ikejiri; B Sredni; B Bonavida; R B Herberman
Journal:  Cell Immunol       Date:  1982-05-15       Impact factor: 4.868

8.  Limit-dilution assay and clonal expansion of all T cells capable of proliferation.

Authors:  W F Chen; A Wilson; R Scollay; K Shortman
Journal:  J Immunol Methods       Date:  1982-08-13       Impact factor: 2.303

9.  Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets.

Authors:  T Timonen; E Saksela; A Ranki; P Häyry
Journal:  Cell Immunol       Date:  1979-11       Impact factor: 4.868

10.  Broadly reactive murine cytotoxic cells induced in vitro under syngeneic conditions.

Authors:  N Dorfman; D Winkler; R C Burton; N Kossayda; P Sabia; J Wunderlich
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

View more
  11 in total

1.  Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.

Authors:  F Ronchese; D Collavo; P Zanovello; V Cerundolo; G Biasi
Journal:  Immunology       Date:  1985-02       Impact factor: 7.397

2.  The analysis of an anti-fluorescein response at limit dilution: the effect of lymphokine preparations on the apparent specificity.

Authors:  M A Skinner; R Prestidge; J Marbrook
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

3.  MHC-unrestricted cytolytic T lymphocytes.

Authors:  A M Krensky; C Clayberger
Journal:  Surv Immunol Res       Date:  1985

4.  AK cells were developed from NK cells during in vitro culture of allogeneic or F1 anti-parental stimulation: functional conversion in recognizing H-2 expression of target cells accompanied by phenotypical conversion.

Authors:  K Taniguchi; Y I Kawano; K Nomoto
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

Review 5.  Neoplastic cells as targets of spontaneously cytotoxic lymphocytes: studies with natural killer-like cell lines.

Authors:  A E Lagarde
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

6.  Antigen-specific cytolysis of infected cells in murine candidiasis.

Authors:  L Romani; S Mocci; E Cenci; A Mencacci; G Sbaraglia; P Puccetti; F Bistoni
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

7.  Lymphocytes from patients with hairy cell leukaemia enable the distinction of two separate subpopulations of activated lymphocyte killer cells generated in mixed lymphocyte culture.

Authors:  J A Werkmeister; A W Boyd; T Triglia; G F Burns
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

8.  Activated lymphocyte killer cells derived from melanoma tissue or peripheral blood.

Authors:  G F Burns; M F Good; C Riglar; P F Bartlett; R M Crapper; I R Mackay
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

9.  TLiSA1, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors.

Authors:  G F Burns; T Triglia; J A Werkmeister; C G Begley; A W Boyd
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

10.  Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.

Authors:  R H Wiltrout; B J Mathieson; J E Talmadge; C W Reynolds; S R Zhang; R B Herberman; J R Ortaldo
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.